Skip to main content
. 2020 May 20;11(7):1934–1943. doi: 10.1111/1759-7714.13485

Figure 5.

Figure 5

Anlotinib inhibits the growth of HCC827 GR cells in vivo. (a) The tumor volumes were measured at the indicated time intervals and calculated. See the Methods section for details (Inline graphic Anlotinib, Inline graphic Gefitinb, and Inline graphic Control). (b) and (c) At the end of treatment, the tumors were excised, photographed as indicated and weighed. (d) Western blotting was used to analyze the levels of p‐FGFR, p‐AKT and p‐ERK in tumor tissues from different treatment groups. (*** P < 0.001).